SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-014023
Filing Date
2015-02-26
Accepted
2015-02-26 06:05:48
Documents
5
Period of Report
2015-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-5217_38k.htm 8-K 29957
2 EX-1.1 a15-5217_3ex1d1.htm EX-1.1 324214
3 EX-5.1 a15-5217_3ex5d1.htm EX-5.1 12139
4 EX-99.1 a15-5217_3ex99d1.htm EX-99.1 9598
5 GRAPHIC g52173mmi001.jpg GRAPHIC 3870
  Complete submission text file 0001104659-15-014023.txt   382725
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 15649988
SIC: 2835 In Vitro & In Vivo Diagnostic Substances